GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Holdings Corp (XKRX:096760) » Definitions » E10

JW Holdings (XKRX:096760) E10 : ₩130.16 (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is JW Holdings E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

JW Holdings's adjusted earnings per share data for the three months ended in Dec. 2024 was ₩107.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩130.16 for the trailing ten years ended in Dec. 2024.

During the past 12 months, JW Holdings's average E10 Growth Rate was 675.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of JW Holdings was 13.20% per year. The lowest was 8.30% per year. And the median was 10.75% per year.

As of today (2025-04-07), JW Holdings's current stock price is ₩3005.00. JW Holdings's E10 for the quarter that ended in Dec. 2024 was ₩130.16. JW Holdings's Shiller PE Ratio of today is 23.09.

During the past 13 years, the highest Shiller PE Ratio of JW Holdings was 19530.44. The lowest was 23.01. And the median was 63.45.


JW Holdings E10 Historical Data

The historical data trend for JW Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Holdings E10 Chart

JW Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -115.42 -68.35 10.85 16.79 130.16

JW Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.79 42.34 89.07 113.68 130.16

Competitive Comparison of JW Holdings's E10

For the Drug Manufacturers - Specialty & Generic subindustry, JW Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JW Holdings's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JW Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where JW Holdings's Shiller PE Ratio falls into.


;
;

JW Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, JW Holdings's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=107/121.1352*121.1352
=107.000

Current CPI (Dec. 2024) = 121.1352.

JW Holdings Quarterly Data

per share eps CPI Adj_EPS
201503 -9.029 99.721 -10.968
201506 14.775 100.051 17.889
201509 -4.925 100.111 -5.959
201512 2.671 100.220 3.228
201603 9.210 100.561 11.094
201606 -95.445 100.791 -114.710
201609 53.583 101.461 63.973
201612 -78.701 101.561 -93.869
201703 -10.047 102.851 -11.833
201706 50.234 102.611 59.302
201709 -18.419 103.491 -21.559
201712 -120.862 102.991 -142.155
201803 24.766 104.101 28.819
201806 687.459 104.130 799.724
201809 -231.430 105.651 -265.350
201812 -120.122 104.351 -139.443
201903 -114.110 104.491 -132.287
201906 -16.550 104.881 -19.115
201909 20.035 105.200 23.070
201912 -280.474 105.121 -323.201
202003 -31.402 105.354 -36.106
202006 -28.710 105.112 -33.087
202009 8.075 106.198 9.211
202012 176.739 105.765 202.423
202103 81.322 107.357 91.759
202106 -31.420 107.579 -35.379
202109 59.143 108.759 65.873
202112 -149.919 109.676 -165.582
202203 83.762 111.848 90.717
202206 0.408 114.072 0.433
202209 119.931 114.715 126.643
202212 101.847 115.179 107.114
202303 233.333 116.507 242.601
202306 -189.216 117.182 -195.599
202309 33.333 118.964 33.941
202312 182.647 118.837 186.179
202403 178.000 120.123 179.500
202406 412.000 120.007 415.872
202409 181.000 120.861 181.410
202412 107.000 121.135 107.000

Add all the adjusted EPS together and divide 10 will get our e10.


JW Holdings  (XKRX:096760) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

JW Holdings's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=3005.00/130.16
=23.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of JW Holdings was 19530.44. The lowest was 23.01. And the median was 63.45.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


JW Holdings E10 Related Terms

Thank you for viewing the detailed overview of JW Holdings's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Holdings Business Description

Traded in Other Exchanges
N/A
Address
698 Sindaebang 1-dong, Dongjak-gu, Seoul, KOR, 156-010
JW Holdings Corp is a healthcare solutions provider. It is a drug manufacturer based in Korea and its key focus areas are raw material, completion medicine, medical supplies and medical appliances. The company's array of products comprises of antimicrobials, antifungals, anticancer and gastrointestinal agents. It licenses and markets in its home country and in regions such as United States, Japan, Germany, and China.

JW Holdings Headlines

No Headlines